Opera Limited
Opera Limited (OPRA) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Opera Limited (OPRA), covering cash flow, earnings, and balance sheets.
Opera Limited (OPRA) Income Statement & Financial Overview
Review Opera Limited OPRA income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $142.72M | $145.83M | $123.21M | $109.73M |
| Cost of Revenue | $50.69M | $47.77M | $33.12M | $27.66M |
| Gross Profit | $92.02M | $98.06M | $90.09M | $82.08M |
| Gross Profit Ratio | $0.64 | $0.67 | $0.73 | $0.75 |
| R&D Expenses | $0.00 | $46.79M | $0.00 | $0.00 |
| SG&A Expenses | $60.60M | $61.15M | $57.89M | $51.97M |
| Operating Expenses | $70.95M | $70.50M | $66.91M | $60.13M |
| Total Costs & Expenses | $121.64M | $118.28M | $100.02M | $87.79M |
| Interest Income | $678000.00 | $994000.00 | $784000.00 | $936000.00 |
| Interest Expense | $120000.00 | $98000.00 | $117000.00 | $173000.00 |
| Depreciation & Amortization | $4.43M | $4.35M | $4.15M | $4.01M |
| EBITDA | $25.34M | $38.48M | $27.05M | $26.31M |
| EBITDA Ratio | $0.18 | $0.26 | $0.22 | $0.24 |
| Operating Income | $21.07M | $27.56M | $23.18M | $21.94M |
| Operating Income Ratio | $0.15 | $0.19 | $0.19 | $0.20 |
| Other Income/Expenses (Net) | -$284000.00 | $6.47M | -$399000.00 | $185000.00 |
| Income Before Tax | $20.79M | $34.03M | $22.79M | $22.13M |
| Income Before Tax Ratio | $0.15 | $0.23 | $0.18 | $0.20 |
| Income Tax Expense | $2.51M | $5.34M | $4.85M | $2.83M |
| Net Income | $18.28M | $28.69M | $17.94M | $19.30M |
| Net Income Ratio | $0.13 | $0.20 | $0.15 | $0.18 |
| EPS | $0.21 | $0.32 | $0.20 | $0.22 |
| Diluted EPS | $0.20 | $0.32 | $0.20 | $0.22 |
| Weighted Avg Shares Outstanding | $89.49M | $88.47M | $88.47M | $88.46M |
| Weighted Avg Shares Outstanding (Diluted) | $90.19M | $89.58M | $89.49M | $89.31M |
Over the past four quarters, Opera Limited demonstrated steady revenue growth, increasing from $109.73M in Q2 2024 to $142.72M in Q1 2025. Operating income reached $21.07M in Q1 2025, maintaining a consistent 15% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $25.34M, reflecting operational efficiency. Net income dropped to $18.28M, with EPS at $0.21. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan